Chemed Corp CHE
We take great care to ensure that the data presented and summarized in this overview for CHEMED CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CHE
View all-
Vanguard Group Inc Valley Forge, PA1.64MShares$776 Million0.02% of portfolio
-
Black Rock Inc. New York, NY1.44MShares$682 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA597KShares$283 Million0.93% of portfolio
-
Neuberger Berman Group LLC New York, NY521KShares$247 Million0.28% of portfolio
-
State Street Corp Boston, MA485KShares$230 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL442KShares$209 Million0.83% of portfolio
-
Geode Capital Management, LLC Boston, MA356KShares$168 Million0.02% of portfolio
-
Morgan Stanley New York, NY314KShares$148 Million0.01% of portfolio
-
Impax Asset Management Group PLC302KShares$143 Million1.25% of portfolio
-
Td Asset Management Inc265KShares$125 Million0.16% of portfolio
Latest Institutional Activity in CHE
Top Purchases
Top Sells
About CHE
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Insider Transactions at CHE
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 19
2025
|
George J Walsh Iii |
BUY
Grant, award, or other acquisition
|
Direct |
277
+7.69%
|
$160,383
$579.04 P/Share
|
May 19
2025
|
John Meredith Mount Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
277
+22.95%
|
$160,383
$579.04 P/Share
|
May 19
2025
|
Eileen P Mc Carthy |
BUY
Grant, award, or other acquisition
|
Direct |
277
+24.47%
|
$160,383
$579.04 P/Share
|
May 19
2025
|
Andrea R Lindell |
BUY
Grant, award, or other acquisition
|
Direct |
277
+4.41%
|
$160,383
$579.04 P/Share
|
May 19
2025
|
Christopher J Heaney |
BUY
Grant, award, or other acquisition
|
Direct |
277
+10.39%
|
$160,383
$579.04 P/Share
|
May 19
2025
|
Patrick P Grace |
BUY
Grant, award, or other acquisition
|
Direct |
277
+7.24%
|
$160,383
$579.04 P/Share
|
May 19
2025
|
Ron De Lyons |
BUY
Grant, award, or other acquisition
|
Direct |
277
+14.26%
|
$160,383
$579.04 P/Share
|
May 16
2025
|
Spencer S Lee executive vice president |
SELL
Open market or private sale
|
Direct |
1,500
-9.3%
|
$865,500
$577.99 P/Share
|
May 09
2025
|
Nicholas Michael Westfall Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
23,000
-69.67%
|
$13,087,000
$569.7 P/Share
|
May 09
2025
|
Nicholas Michael Westfall Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
26,088
+32.17%
|
$11,817,864
$453.7 P/Share
|
May 07
2025
|
Spencer S Lee executive vice president |
SELL
Open market or private sale
|
Direct |
1,500
-8.51%
|
$865,500
$577.86 P/Share
|
May 05
2025
|
Kevin J Mcnamara president and CEO |
SELL
Open market or private sale
|
Direct |
1,500
-1.46%
|
$864,000
$576.45 P/Share
|
May 05
2025
|
Kevin J Mcnamara president and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,982
-8.04%
|
$5,155,668
$574.02 P/Share
|
May 05
2025
|
Kevin J Mcnamara president and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.22%
|
$4,710,000
$471.74 P/Share
|
Mar 31
2025
|
Kevin J Mcnamara president and CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.97%
|
$615,000
$615.33 P/Share
|
Mar 10
2025
|
Michael D Witzeman VP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,494
-56.97%
|
$4,496,400
$600.92 P/Share
|
Mar 10
2025
|
Michael D Witzeman VP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,796
+40.07%
|
$3,914,220
$445.35 P/Share
|
Mar 06
2025
|
Kevin J Mcnamara president and CEO |
SELL
Open market or private sale
|
Direct |
2,000
-1.91%
|
$1,186,000
$593.67 P/Share
|
Mar 03
2025
|
Spencer S Lee executive vice president |
SELL
Open market or private sale
|
Direct |
1,326
-7.0%
|
$784,992
$592.25 P/Share
|
Feb 14
2025
|
Spencer S Lee executive vice president |
SELL
Payment of exercise price or tax liability
|
Direct |
342
-1.77%
|
$189,126
$553.39 P/Share
|
Last 12 Months Summary
Exercise of conversion of derivative security | 92K shares |
---|---|
Grant, award, or other acquisition | 1.94K shares |
Open market or private purchase | 145 shares |
Payment of exercise price or tax liability | 76.2K shares |
---|---|
Open market or private sale | 27.5K shares |
Bona fide gift | 65 shares |